Therapeutic monoclonal antibodies have become the predominant treatment modality for various diseases over the past 25 years. As a result of the COVID-19 pandemic, several neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have...
Neutralizing antibodies are those that block the interaction between the SARS-CoV-2 virus and the host cells preventing infection, which is why they are of great relevance in research against COVID-19. Most neutralizing antibodies to SARS-CoV-2 react with the...
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!